Simulations Plus

Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules solely from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company provides specific proprietary software products, such as GastroPlus, a physiologically-based simulation tool that predicts the absorption, pharmacokinetics, pharmacodynamics, and drug-drug interactions for compounds administered through intravenous, oral, ocular, or pulmonary routes; ADMET Predictor, an ADME-Tox property prediction, and model building application; MedChem Studio, a multi-purpose cheminformatics platform used for advanced data mining and de novo molecule design; DDDPlus, a simulation program for formulation scientists that predicts the in vitro disintegration and dissolution of solid dosage forms under different experimental conditions;  MedChem Designer, a free chemical sketching product that combines innovative molecule drawing features with fast and accurate ADMET property predictions from ADMET Predictor.

Company Growth (employees)
Type
Public
HQ
Lancaster, US
Founded
1996
Size (employees)
60 (est)
Simulations Plus was founded in 1996 and is headquartered in Lancaster, US

Simulations Plus Office Locations

Simulations Plus has offices in Lancaster and Buffalo
Lancaster, US (HQ)
42505 10th St W
Buffalo, US
110 1780 Wehrle Dr

Simulations Plus Financials and Metrics

Simulations Plus Financials

Simulations Plus's revenue was reported to be $24.1 m in FY, 2017
USD

Revenue (FY, 2017)

24.1 m

Gross profit (FY, 2017)

17.8 m

Gross profit margin (FY, 2017), %

74%

Net income (FY, 2017)

5.8 m

EBIT (FY, 2017)

8.3 m

Market capitalization (13-Dec-2017)

280.3 m

Cash (31-Aug-2017)

6.2 m
Simulations Plus's current market capitalization is $280.3 m.
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

11.5 m18.3 m20 m24.1 m

Revenue growth, %

60%9%

Cost of goods sold

1.6 m4.3 m4.6 m6.3 m

Gross profit

9.8 m14 m15.4 m17.8 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

4.1 m4.6 m5.9 m4.8 m5.2 m6 m5.4 m5.7 m6.7 m

Cost of goods sold

997.7 k1.1 m1.1 m1.1 m1.3 m1.2 m1.3 m1.6 m1.4 m

Gross profit

3.1 m3.4 m4.8 m3.8 m3.9 m4.8 m4.1 m4.2 m5.3 m

Gross profit Margin, %

76%75%81%78%76%80%75%73%79%
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

8.6 m8.6 m8 m6.2 m

Accounts Receivable

8 m(876.2 k)

Inventories

188.2 k381.7 k410.8 k459.9 k

Current Assets

11.5 m11.5 m12.9 m12.7 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

5.8 m6.1 m6.4 m7.2 m7.1 m7.3 m8.8 m7.4 m8.2 m

Current Assets

10.7 m10.7 m11.8 m12.4 m12.5 m13.6 m13.6 m14 m14.9 m

PP&E

518.4 k460.3 k420.6 k364.5 k317 k297.4 k272 k280.6 k257.6 k

Goodwill

4.8 m4.8 m4.8 m4.8 m4.8 m4.8 m4.8 m4.8 m4.8 m
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    3 m3.8 m5 m5.8 m

    Accounts Receivable

    1 m(1.4 m)(876.2 k)

    Inventories

    192.2 k459.9 k

    Accounts Payable

    146 k(15.5 k)19.4 k(101.3 k)240.9 k
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    528.9 k970.2 k1.9 m1.1 m2.3 m1.9 m1.4 m1.2 m2.1 m

    Accounts Receivable

    (2.4 m)(2.2 m)

    Accounts Payable

    235.4 k306.7 k177.4 k153.2 k120.7 k133.1 k(119.3 k)(83.3 k)185 k211.8 k221.4 k211.6 k

    Cash From Operating Activities

    (360.1 k)652.4 k
      USDY, 2017

      Revenue/Employee

      402.3 k

      Financial Leverage

      1.5 x
      Show all financial metrics

      Simulations Plus Market Value History

      Simulations Plus's Web-traffic and Trends

      Simulations Plus Online and Social Media Presence

      Simulations Plus Company Life and Culture

      You may also be interested in